Vabysmo Faricimab 120mg Injection
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
How It Works
Vabysmo Faricimab is a groundbreaking medication used to treat various retinal diseases. It functions by targeting and inhibiting two key proteins in the eye: angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF-A). By blocking the activity of these proteins, Vabysmo helps to reduce abnormal blood vessel growth and leakage in the retina, which are common features of conditions like age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR). This dual inhibition approach offers a more comprehensive treatment for retinal diseases compared to traditional therapies.List of Side Effects
- Eye irritation or discomfort
- Increased sensitivity to light
- Blurred vision
- Eye redness
- Eye pain
List of Indications
- Age-related macular degeneration (AMD)
- Diabetic macular edema (DME)
- Diabetic retinopathy (DR)
List of Contraindications
- Hypersensitivity to Faricimab or any of its components
- Active ocular or periocular infection
- Untreated or inadequately treated eye inflammation
Price in Different Countries
Country | Price (USD) | Reference Website |
---|---|---|
United States | $1000 | Drugs.com |
United Kingdom | ?800 | NHS UK |
Canada | $1200 CAD | CanadaDrugs.com |
Australia | $1300 AUD | Chemist Warehouse |
India | ?70000 INR | Medlife |
Top 5 Global Brands
- Vabysmo Faricimab (Roche)
- Eylea (Aflibercept, Regeneron Pharmaceuticals)
- Lucentis (Ranibizumab, Genentech)
- Beovu (Brolucizumab, Novartis)
- Ozurdex (Dexamethasone implant, Allergan)
Related products
-
Uncategorized
Ivosidenib (Tibsovo): A Novel Treatment for Acute Myeloid Leukemia
Rated 0 out of 5Get Price